1. Therapeutic drug monitoring of oral targeted antineoplastic drugs

   • Anna Mueller-Schoell
   • Stefanie L. Groenland
   • Charlotte Kloft

   Review Open access 09 November 2020 Pages: 441 - 464

2. Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs

   • Anna Mueller-Schoell
   • Stefanie L. Groenland
   • Charlotte Kloft

   Correction 15 December 2020 Pages: 465 - 465

3. Interventions to optimize prescribed medicines and reduce their misuse in chronic non-malignant pain: a systematic review

   • Aziza Alenezi
   • Asma Yahyouche
   • Vibhu Paudyal

   Review Open access 30 October 2020 Pages: 467 - 490

   

4. Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis

   • Min Li
   • Jiarong Lan
   • Peixin Duan

   Review 07 November 2020 Pages: 491 - 507

   

5. Appropriate use of essential medicines in the elderly: a comparison of the WHO essential medicines list and PIM criteria

   • Xin Ma
   • Xuxu Yin
   • Wei Liu

   Review 12 November 2020 Pages: 509 - 516

   

6. ImpaCt of aspirin regimen on THrombin generation in diabEtic patients with acute coronary syndrome: CARTHaGE-ACS trial

   • Amine Boussofara
   • Lobna Laroussi
   • Salem Kachboura

   Clinical Trial 06 August 2020 Pages: 517 - 526

   

7. Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects

   • Michael Boettcher
   • Dirk Thomas
   • Corina Becker

   Clinical Trial Open access 30 October 2020 Pages: 527 - 537

   

8. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials

   • Rafael Dal-Ré

   Clinical Trial 26 October 2020 Pages: 539 - 546

   

9. Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial

   • Akram Sadat Razavizadeh
   • Nasim Zamani
   • Hossein Hassanian-Moghaddam

   Clinical Trial 30 October 2020 Pages: 547 - 554

   

10. Correction to: Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial

    • Akram Sadat Razavizadeh
    • Nasim Zamani
    • Hossein Hassanian-Moghaddam

    Correction 26 February 2021 Pages: 555 - 556

    

11. The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research

    • Zejuan Wang
    • Gang Chen
    • Jin Wang

    Pharmacoeconomics 13 November 2020 Pages: 557 - 568

12. Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis

    • Qian Xiang
    • Xiao-Dan Zhang
    • Yi-Min Cui

    Pharmacokinetics and Disposition 04 November 2020 Pages: 569 - 581

    

13. Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients

    • Xueting Yao
    • Xiaoyu Yan
    • Dongyang Liu

    Pharmacokinetics and Disposition Open access 13 November 2020 Pages: 583 - 593

    

14. Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology

    • Chenxia Hao
    • Xiaoqin Ma
    • Wanhua Yang

    Pharmacokinetics and Disposition 11 November 2020 Pages: 595 - 605

    

15. Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model

    • Gabriel Stillemans
    • Leila Belkhir
    • Laure Elens

    Pharmacokinetics and Disposition Open access 11 November 2020 Pages: 607 - 616

    

16. Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study

    • Anne Mette Skov Sørensen
    • Lotte Rasmussen
    • Anton Pottegård

    Pharmacoepidemiology and Prescription Open access 28 October 2020 Pages: 617 - 624

    

17. Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists

    • Camille E. van Hoorn
    • Robert B. Flint
    • Jurgen C. de Graaff

    Pharmacoepidemiology and Prescription Open access 29 October 2020 Pages: 625 - 635

    

18. Patients’ contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions

    • J. Riera-Arnau
    • L. A. Alvarado Aguirre
    • G. Cereza García

    Pharmacoepidemiology and Prescription 10 November 2020 Pages: 637 - 642

19. Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department

    • Mirjam Kauppila
    • Janne T. Backman
    • Outi Lapatto-Reiniluoto

    Pharmacoepidemiology and Prescription Open access 13 November 2020 Pages: 643 - 650